Identifying susceptibility to cardiac hypertrophy

Details Identifying susceptibility to cardiac hypertrophy Identifying susceptibility to cardiac hypertrophy

2006-11-01

2009-08-11

Horlick, Kenneth R. (Department: 1637)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S091200, C536S024300

Reexamination Certificate

active

07572586

ABSTRACT:
This document provides methods and materials related to identifying, assessing, and predicting hypertrophic cardiomyopathy (HCM) in mammals. For example, methods and materials for using mutations (e.g., mutations in ZASP and MYBPC3 nucleic acids) to identify, assess, and predict HCM in mammals (e.g., humans) are provided.

REFERENCES:
patent: 5382510 (1995-01-01), Levine et al.
patent: 5648482 (1997-07-01), Meyer
patent: 2002/0127548 (2002-09-01), Siedman et al.
patent: WO 99/57318 (1999-11-01), None
Andersen et al., European Journal of Human Genetics 12(8), 673-677 (Aug. 2004).
Erdmann et al., Clinical Genetics 64(4), 339-349 (2003).
Morner et al., Journal of Molecular and Cellular Cardiology 35(7), 841-849 (2003).
GenBank Accession No. NM—000256, dated Jun. 26, 2007, 8 pages.
GenBank Accession No. NM—007078, dated Jul. 30, 2007, 6 pages.
Ackerman et al., “A Novel Mutation in KVLQT1 Is the Molecular Basis of Inherited Long QT Syndrome in a Near-Drowning Patient's Family,”Pediatr. Res., 1998, 44:148-153.
Jääskeläinen et al., “Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland,”J. Mol. Med., 2002, 80:412-422.
Lamke et al., “Surgical pathology of subaortic septal myectomy associated with hypertrophic cardiomyopathy: A study of 204 cases (1996-2000),”Cardiovasc. Pathol., 2003, 12:149-158.
Prince et al., “Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation,”Genome Res., 2001, 11(1):152-162.
Rost et al., “The PredictProtein server,”Nucl. Acids Res., 2004, 32:W321-326.
Schafer et al., “DNA variation and the future of human genetics,”Nat. Biotechnol., 1998, 15:33-39.
Stoneking et al., “Population variation of human mtDNA control region sequences detected by enzymatic amplification and sequence-specific oligonucleotide probes,”Am. J. Hum. Genet., 1991, 48:370-382.
Underhill et al., “Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography,”Genome Res., 1997, 7:996-1005.
Van Driest et al., “Myosin Binding Protein C Mutations and Compound Heterozygosity in Hypertrophic Cardiomyopathy,”J. Am. Coll. Cardiol., 2004, 44:1903-1910.
Van Driest et al., “Comprehensive Analysis of the Beta-Myosin Heavy Chain Gene in 389 Unrelated Patients With Hypertrophic Cardiomyopathy,”J. Am. Coll. Cardiol., 2004, 44:602-610.
Vatta et al., “Mutations inCypher/ZASPin Patients With Dilated Cardiomyopathy and Left Ventricular Non-Compaction,”J. Am. Coll. Cardiol., 2003, 42(11):2014-2027.

Affiliated with

Also associated with

Rating

Identifying susceptibility to cardiac hypertrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Identifying susceptibility to cardiac hypertrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identifying susceptibility to cardiac hypertrophy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4102571